A survival benefit from axillary dissection: was Halsted correct?

Morrow M

doi:10.1007/s10434-999-0017-4

A survival benefit from axillary dissection: was Halsted correct?

Annals of Surgical Oncology, 01 Jan 1999, 6(1):17-18
https://doi.org/10.1007/s10434-999-0017-4 PMID: 10030410

This is a comment on "The impact of prophylactic axillary node dissection on breast cancer survival--a Bayesian meta-analysis." Ann Surg Oncol. 1999 Jan-Feb;6(1):109-16.

Abstract

No abstract provided.

Full text links

Read article at publisher's site: https://doi.org/10.1007/s10434-999-0017-4

References

Articles referenced by this article (8)

Laboratory and clinical research in breast cancer--a personal adventure: the David A. Karnofsky memorial lecture.
Fisher B
Cancer Res, (11):3863-3874 1980
MED: 7008932
The impact of prophylactic axillary node dissection on breast cancer survival--a Bayesian meta-analysis.
Orr RK
Ann Surg Oncol, (1):109-116 1999
MED: 10030423
Hayward JL The Guy?s Hospital trials on breast conservation. In: Harris JR, Hellman S, Silen W, eds. Conservative management of breast cancer. New surgical and radiotherapeutic techniques. New York: JB Lippincott, 1983:77-90.
Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation.
Fisher B, Redmond C, Fisher ER, Bauer M, Wolmark N, Wickerham DL, Deutsch M, Montague E, Margolese R, Foster R
N Engl J Med, (11):674-681 1985
MED: 3883168
Staging of breast cancer: a new rationale for internal mammary node biopsy.
Morrow M, Foster RS Jr
Arch Surg, (6):748-751 1981
MED: 7016069
Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial.
Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F, Kjaer M, Gadeberg CC, Mouridsen HT, Jensen MB, Zedeler K
N Engl J Med, (14):949-955 1997
MED: 9395428
Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer.
Ragaz J, Jackson SM, Le N, Plenderleith IH, Spinelli JJ, Basco VE, Wilson KS, Knowling MA, Coppin CM, Paradis M, Coldman AJ, Olivotto IA
N Engl J Med, (14):956-962 1997
MED: 9309100
Natural history of node-positive breast cancer: the curability of small cancers with a limited number of positive nodes.
Quiet CA, Ferguson DJ, Weichselbaum RR, Hellman S
J Clin Oncol, (12):3105-3111 1996
MED: 8955655

Citations & impact

Impact metrics

Citations

Jump to Citations

Citations of article over time

Article citations

Management of axilla in breast cancer - The saga continues.
Layeequr Rahman R, Crawford SL, Siwawa P
Breast, 24(4):343-353, 27 Apr 2015
Cited by: 6 articles | PMID: 25937264
Review
Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma.
Eyles J, Puaux AL, Wang X, Toh B, Prakash C, Hong M, Tan TG, Zheng L, Ong LC, Jin Y, Kato M, Prévost-Blondel A, Chow P, Yang H, Abastado JP
J Clin Invest, 120(6):2030-2039, 24 May 2010
Cited by: 325 articles | PMID: 20501944 | PMCID: PMC2877955
Free full text in Europe PMC
Low performance of the MSKCC nomogram in preoperatively ultrasonically negative axillary lymph node in breast cancer patients.
Zgajnar J, Perhavec A, Hocevar M, Podkrajsek M, Hertl K, Frkovic-Grazio S, Pohar M, Besic N
J Surg Oncol, 96(7):547-553, 01 Dec 2007
Cited by: 24 articles | PMID: 17708546
Accuracy of frozen section of sentinel lymph nodes: a prospective analysis of 659 breast cancer patients of the Swiss multicenter study.
Langer I, Guller U, Berclaz G, Koechli OR, Moch H, Schaer G, Fehr MK, Hess T, Oertli D, Bronz L, Schnarwyler B, Wight E, Uehlinger U, Infanger E, Burger D, Zuber M, Swiss Multicenter Study Group Sentinel Lymph Node in Breast Cancer
Breast Cancer Res Treat, 113(1):129-136, 23 Feb 2008
Cited by: 19 articles | PMID: 18297394
Is there any prognostically different subgroup among patients with stage IIIC (any TN3M0) breast carcinoma?
Duraker N, Caynak ZC, Bati B
Ann Surg Oncol, 15(2):430-437, 03 Oct 2007
Cited by: 13 articles | PMID: 17912589

Go to all (20) article citations

Search life-sciences literature (45,103,589 articles, preprints and more)

A survival benefit from axillary dissection: was Halsted correct?

Abstract

Full text links

References

Laboratory and clinical research in breast cancer--a personal adventure: the David A. Karnofsky memorial lecture.

The impact of prophylactic axillary node dissection on breast cancer survival--a Bayesian meta-analysis.

Hayward JL The Guy?s Hospital trials on breast conservation. In: Harris JR, Hellman S, Silen W, eds. Conservative management of breast cancer. New surgical and radiotherapeutic techniques. New York: JB Lippincott, 1983:77-90.

Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation.

Staging of breast cancer: a new rationale for internal mammary node biopsy.

Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial.

Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer.

Natural history of node-positive breast cancer: the curability of small cancers with a limited number of positive nodes.

Citations & impact

Impact metrics

Citations of article over time

Article citations

Management of axilla in breast cancer - The saga continues.

Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma.

Low performance of the MSKCC nomogram in preoperatively ultrasonically negative axillary lymph node in breast cancer patients.

Accuracy of frozen section of sentinel lymph nodes: a prospective analysis of 659 breast cancer patients of the Swiss multicenter study.

Is there any prognostically different subgroup among patients with stage IIIC (any TN3M0) breast carcinoma?

Similar Articles

[Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].

-Breast neoplasms: axillary lymph node excision--at what price-.

-Axillary lymph node excision: for what reasons and indications-.

Role of axillary sampling in the era of sentinel lymph node biopsy: a critical review.

Partnerships & funding

Similar Articles

[Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
Orv Hetil, 154(49):1934-1942, 01 Dec 2013

-Breast neoplasms: axillary lymph node excision--at what price-.
Arch Gynecol Obstet, 256 Suppl:S85-92, 01 Jan 1995

-Axillary lymph node excision: for what reasons and indications-.
Arch Gynecol Obstet, 256 Suppl:S81-4, 01 Jan 1995

Role of axillary sampling in the era of sentinel lymph node biopsy: a critical review.